JP7255734B2 - Mixed injection support system - Google Patents

Description

TECHNICAL FIELD The present invention relates to a co-injection support system for assisting co-infusion of drugs such as anticancer drugs.

In a hospital or a pharmacy, a pharmacist performs a co-injection operation of mixing a drug such as an anticancer drug with a solution such as a physiological saline solution. At this time, a co-infusion support system may be used that assists the pharmacist performing the co-infusion work by displaying information necessary for the co-infusion work on a display device (see, for example, Patent Document 1).

JP 2007-260390 A JP 2006-122816 A

By the way, in the co-infusion support system, when a large amount of information is displayed on the display device as information necessary for co-infusion work, the pharmacist selects necessary information and unnecessary information for each work process in the co-infusion work. It is necessary to organize the work efficiency.

An object of the present invention is to provide a co-infusion support system capable of improving the work efficiency of co-infusion work.

A co-infusion support system according to the present invention includes a display unit and a control unit that sequentially displays information on each work process included in a drug co-infusion operation on the display unit. Then, when the control unit displays information of a predetermined specific work process among the work processes, only the content of the work process, the amount of work, and the work target are displayed as the information of the specific work process. display on the display.

A co-infusion support system according to another aspect of the present invention includes a display unit and a control unit that sequentially displays information on each work process included in a drug co-infusion operation on the display unit. Then, when the control unit displays information of a predetermined specific work process among the work processes, only the content of the work process, the amount of work, and the work target are displayed as the information of the specific work process. A display is caused to display, and a status area indicating a color preliminarily associated with the current specific work process is displayed on the display.

A co-infusion support system according to another aspect of the present invention includes a display unit and a control unit that sequentially displays information on each work process included in a drug co-infusion operation on the display unit. Then, when the control unit displays information of a predetermined specific work process among the work processes, only the content of the work process, the amount of work, and the work target are displayed as the information of the specific work process. When the same specific work process is repeatedly displayed, a medicine number display area showing the planned number of execution and the number of completed execution of the same specific work process is displayed on the display section. Let

A co-infusion support system according to another aspect of the present invention includes a display unit and a control unit that sequentially displays information on each work process included in a drug co-infusion operation on the display unit. Then, when the control unit displays information of a predetermined specific work process among the work processes, only the content of the work process, the amount of work, and the work target are displayed as the information of the specific work process. It is caused to display on the display unit, and at least display an operation display area for operating forward or backward for the specific work process.

For example, the content of the work process is a pictogram preset corresponding to the content of the work process.

The co-infusion support system may further include a second display having a larger screen size than the first display, with the display being the first display. In this case, the control unit causes the second display unit to also display the information on the work process, and the amount of information on the work process displayed on the first display unit is reduced by the second display unit. It is conceivable that the amount of information is smaller than the information amount of the work process displayed in the section.

Further, it is conceivable that the co-infusion support system further includes a wearable terminal that can be worn by the co-infusion operator, and the first display section is provided on the wearable terminal. Furthermore, the co-infusion support system may further include a read-aloud processing unit that reads out information on the work process by voice.

When the work target is a drug name, it is conceivable that the control unit displays an abbreviation excluding the standard of the drug name. In particular, the control unit causes the display unit to display the name of the drug without omission in a drug authentication process for authenticating the drug among the work processes, and displays the name of the drug without omission in the other work processes after the end of the drug authentication process. When displaying the drug name, it is conceivable to display an abbreviation of the drug name on the display section.

Further, when the work target is a drug name, it is conceivable that the control unit can display a drug image as the work target. Further, it is conceivable that the control unit can alternately switch between a state in which the content of the work process, the amount of work, and the work target are displayed and a state in which the medicine image is displayed. Furthermore, it is conceivable that the co-injection support system includes a drug update processing unit that updates the drug image based on a preset drug database.

In addition, the co-infusion support system includes a wearable terminal that can be worn by an operator of the co-infusion work and includes the display unit and the imaging unit, a reading processing unit that reads information from the code information captured by the imaging unit, and It is conceivable to provide a setting processing unit that sets the contents of setting items related to the wearable terminal based on the information read by the reading processing unit.

In particular, the setting processing unit transitions the reading processing unit to a standby state in which the information can be read with activation of the wearable terminal, and before a first upper limit time set in advance elapses, the If the information is read by the reading processing unit, the content of the setting items related to the wearable terminal is set based on the information, and if the information is not read by the reading processing unit before the first upper limit time elapses It is conceivable to cancel the standby state.

Another embodiment of the co-infusion support system according to the present invention includes a wearable terminal that can be worn by a worker for drug co-infusion work and is equipped with a display unit and an imaging unit, and information on each work process included in the co-infusion work. on the display unit; a reading processing unit that reads information from the code information captured by the imaging unit; After transitioning to the state, if information is read by the reading processing unit before the first upper limit time set in advance elapses, the contents of setting items related to the wearable terminal are set based on the information, and the first and a setting processing unit that cancels the standby state when the information is not read by the reading processing unit before one upper limit time elapses.

The setting processing unit maintains the standby state after setting the setting item based on the information read by the reading processing unit within the first upper limit time, and then maintains the standby state for a second upper limit time set in advance. If information is read by the reading processing unit within an interval of less than or equal to, setting the content of the setting item based on the information and maintaining the standby state, and before the second upper limit time elapses, the reading processing unit It is conceivable that the standby state is released when the information is not read by the device.

Also, one of the setting items may include one or both of the display mode of the display unit and the connection destination of the wearable terminal. Further, it is conceivable that the display modes include a right-eye mode in which the worker views the display unit with the right eye and a left-eye mode in which the worker views the display unit with the left eye.

Further, one code information includes information about setting contents of a plurality of setting items, and the setting processing unit reads the plurality of setting items at once based on the information read by the reading processing unit. can be set to

Further, the co-infusion support system includes a storage unit that stores a history of the setting items set by the setting processing unit, and the setting processing unit reads the setting items by the reading processing unit in the standby state. It is conceivable that unset items that have not been set based on the information provided are set based on the history stored in the storage unit.

Further, the mixed injection support system includes a storage unit that stores the setting items corresponding to each worker, and the setting processing unit stores the worker in the information read by the reading processing unit in the standby state. If identifiable information is included, it is conceivable to read out the setting items corresponding to the worker from the storage unit and set them.

ADVANTAGE OF THE INVENTION According to this invention, the co-infusion support system which can improve the work efficiency of co-infusion work is provided.

FIG. 1 is a block diagram showing an example of a co-infusion support system according to an embodiment of the present invention. FIG. 2 is an external schematic diagram showing an example of the co-infusion support system according to the embodiment of the present invention. FIG. 3 is a diagram showing the state of use of the safety cabinet used in the co-infusion support system according to the embodiment of the present invention. FIG. 4 is an external schematic diagram showing an example of a wearable terminal of the co-infusion support system according to the embodiment of the present invention. FIG. 5 is a flow chart illustrating an example of the procedure of co-infusion support processing executed by the co-infusion support system according to the embodiment of the present invention. FIG. 6A is a diagram showing an example of a display screen displayed by the co-infusion support system according to the embodiment of the present invention. FIG. 6B is a diagram showing an example of a display screen displayed by the co-infusion support system according to the embodiment of the present invention. FIG. 7 is a flow chart illustrating an example of the procedure of display control processing executed by the co-infusion support system according to the embodiment of the present invention. FIG. 8 is a diagram showing an example of a display screen displayed in the co-infusion support system according to the embodiment of the present invention. FIG. 9 is a diagram showing an example of a display screen displayed by the co-infusion support system according to the embodiment of the present invention. FIG. 10 is a diagram showing an example of a display screen displayed by the co-infusion support system according to the embodiment of the present invention. FIG. 11 is a diagram showing an example of a display screen displayed by the co-infusion support system according to the embodiment of the present invention. FIG. 12 is a diagram showing an example of a display screen displayed by the co-infusion support system according to the embodiment of the present invention. FIG. 13 is a diagram showing an example of a display screen displayed by the co-infusion support system according to the embodiment of the present invention. FIG. 14 is a diagram showing an example of a display screen displayed by the co-infusion support system according to the embodiment of the present invention. FIG. 15 is a diagram showing an example of a display screen displayed by the co-infusion support system according to the embodiment of the present invention. FIG. 16 is a diagram showing an example of a display screen displayed by the co-infusion support system according to the embodiment of the present invention. FIG. 17 is a diagram showing an example of a display screen displayed by the co-infusion support system according to the embodiment of the present invention. FIG. 18 is a diagram showing an example of a display screen displayed by the co-infusion support system according to the embodiment of the present invention. FIG. 19A is a diagram showing an example of a display screen displayed by the co-infusion support system according to the embodiment of the present invention. FIG. 19B is a diagram showing an example of a display screen displayed by the co-infusion support system according to the embodiment of the present invention. FIG. 19C is a diagram showing an example of a display screen displayed by the co-infusion support system according to the embodiment of the present invention. FIG. 20 is a diagram showing an example of a display screen displayed in the co-infusion support system according to the embodiment of the present invention. FIG. 21 is a diagram showing an example of a display screen displayed by the co-infusion support system according to the embodiment of the present invention. FIG. 22 is a diagram showing an example of a display screen displayed by the co-infusion support system according to the embodiment of the present invention. FIG. 23 is a diagram showing an example of a display screen displayed by the co-infusion support system according to the embodiment of the present invention. FIG. 24 is a diagram showing an example of a display screen displayed by the co-infusion support system according to the embodiment of the present invention. FIG. 25A is a diagram showing an example of a display screen displayed by the co-infusion support system according to the embodiment of the present invention. FIG. 25B is a diagram showing an example of a display screen displayed by the co-infusion support system according to the embodiment of the present invention. FIG. 25C is a diagram showing an example of a display screen displayed by the co-infusion support system according to the embodiment of the present invention. FIG. 26 is a diagram showing an example of a display screen displayed in the co-infusion support system according to the embodiment of the present invention. FIG. 27 is a diagram showing an example of a display screen displayed in the co-infusion support system according to the embodiment of the present invention. FIG. 28 is a flow chart showing an example of drug image update processing executed by the co-infusion support system according to the embodiment of the present invention. FIG. 29 is a flow chart showing an example of setting processing executed by the co-infusion support system according to the embodiment of the present invention. FIG. 30A is a diagram showing an example of a display screen displayed on the wearable terminal in the co-infusion support system according to the embodiment of the present invention. FIG. 30B is a diagram showing an example of a display screen displayed on the wearable terminal in the co-infusion support system according to the embodiment of the present invention. FIG. 30C is a diagram showing an example of a display screen displayed on the wearable terminal in the co-infusion support system according to the embodiment of the present invention.

BEST MODE FOR CARRYING OUT THE INVENTION Hereinafter, embodiments of the present invention will be described with reference to the accompanying drawings for understanding of the present invention. It should be noted that the following embodiment is an example that embodies the present invention, and is not intended to limit the technical scope of the present invention.

[Co-infusion support system 1]
First, the configuration of the co-infusion support system 1 will be described with reference to FIGS. 1 to 4. FIG. As shown in FIGS. 1 and 2, the co-infusion support system 1 according to the embodiment of the present invention includes a co-infusion control unit 11, an operation display unit 12, a first reading unit 13, a printer 14, a foot switch unit 15, and a wearable terminal. 16, a second reading unit 21, a weighing unit 22, and the like. The co-infusion support system 1 is used to improve the efficiency of drug co-infusion work performed by a worker such as a doctor or a pharmacist.

Specifically, in the co-infusion work, the operator may perform the work of aspirating the drug solution from the drug container with a syringe and injecting it into an infusion bag containing a dissolving solution such as physiological saline. In the co-infusion work, the operator aspirates a solution such as physiological saline from the infusion bag with a syringe, injects it into the drug container containing the powder, dissolves the powder, and after the dissolution In some cases, the drug solution is aspirated with a syringe and injected into an infusion bag.

As shown in FIG. 2, the second reading unit 21 and the weighing unit 22 are arranged in a working room 101 of a safety cabinet 100 where an operator performs mixed injection work. On the other hand, the mixed injection control unit 11 , the operation display unit 12 , the first reading unit 13 , the printer 14 , the foot switch unit 15 and the wearable terminal 16 are arranged outside the working room of the safety cabinet 100 .

The safety cabinet 100 comprises a working room 101 partitioned by a glass door 102 whose front is transparent. Further, the glass door 102 is supported at a position where an opening 103 is formed below, and the worker can access the work chamber 101 through the opening 103 . The safety cabinet 100 is also provided with an air purifier 104 having a HEPA filter for purifying the air in the working room 101 and exhausting the air.

Then, as shown in FIG. 3, the operator inserts both hands into the work chamber 101 from the open portion 103, and while visually observing the work chamber 101, performs the mixed injection work of chemicals. In the co-infusion support system 1, a clean bench or the like may be used instead of the safety cabinet 100 when non-toxic chemicals such as high-calorie infusions are co-infused.

The second reading unit 21 provided in the safety cabinet 100 is a code reading device capable of reading code information such as a one-dimensional code or a two-dimensional code attached to the drug container of the drug used in the mixed injection work. be. The two-dimensional code is, for example, a QR code (registered trademark). The code information includes identification information for specifying the type of medicine. The code information read by the second reading section 21 is input to the mixed injection control section 11 .

The weighing unit 22, which is also provided in the safety cabinet 100, is an electronic balance used for various weighings in the mixed injection work. The weighing result of the weighing unit 22 is input to the mixed injection control unit 11 in real time. In addition, the weighing unit 22 inputs stability information indicating whether or not the weighing result is stable to the co-infusion control unit 11 . As a result, the co-infusion control unit 11 can acquire information such as the result of weighing by the weighing unit 22 and the presence or absence of stability. In addition, the co-injection control unit 11 may be configured to be able to actively read information such as the weighing result of the weighing unit 22 and the presence or absence of stability.

The co-infusion control unit 11 is communicably connected to a host system wirelessly or by wire through a communication network such as LAN, WAN, Internet, or intranet. The upper system is an electronic medical record system, an ordering system, a receipt system, or the like, and the co-infusion control unit 11 acquires preparation data (prescription data) indicating the content of the co-infusion work performed by the operator from the higher system. It is possible.

For example, the preparation data includes patient information (patient ID, patient name, height, weight, body surface area, etc.), preparation date, drug information (drug code, drug name, etc.), dosage, regimen identification information, and the like. The regimen identification information is information capable of identifying regimen information such as a therapy name (regimen name), therapy ID, or regimen ID. In addition, the preparation data includes doctor information, type of drug container (ampule containing drug solution, vial bottle containing drug solution, vial bottle containing powder drug, or infusion bag, etc.), preparation content information (medicine container, syringe, type and number of injection needles, etc.), preparation procedure information (work content, dissolving drug, solvent, amount of dissolving drug, amount of solvent, sampling amount), date of administration, prescription classification, clinical department, ward, etc. may

The mixed injection control unit 11 is a computer having a CPU 111, a RAM 112, a storage unit 113, and the like. The CPU 111 is a processor that executes various kinds of arithmetic processing. The RAM 112 is a volatile storage unit, and is used as a temporary storage memory (work area) for various processes executed by the CPU. The storage unit 113 is a non-volatile storage unit such as an HDD or SSD in which information such as control programs for causing the CPU 111 to execute various processes is stored. The mixed injection control unit 11 uses the CPU 111 and the RAM 112 to execute various processes according to various control programs pre-stored in the storage unit 113 .

The storage unit 113 includes storage areas such as a data area, a program area, and a master area. Note that the storage unit 113 may include a plurality of storage media such as HDDs and semiconductor memories, and the data area, the program area, and the master area may be distributed over the plurality of storage media. .

The preparation data acquired from the host system is accumulated and stored in the data area. In the co-infusion control unit 11, it is also possible to newly register or edit the preparation data according to the user's operation. Further, in the data area, history data indicating details of co-infusion work performed by the operator according to the preparation data is stored in association with the preparation data. For example, the history data includes the operator of the co-infusion work, the start time of the work, the end time of the work, and the photographed images taken during the co-infusion work.

The program area stores a control program for causing the co-infusion control unit 11 to execute a co-infusion support process (see FIG. 5), which will be described later. The program area also stores an operating system (OS) and application programs such as browser software.

Various kinds of master information such as drug master, patient master, ward master, doctor master, and pharmacist master are stored in the master area. For example, the drug master includes drug ID, drug name, drug code, drug bottle code, category (dosage form: powdered medicine, tablet, liquid medicine, topical medicine, etc.), specific gravity, drug type (ordinary drug, anticancer drug , poisonous drugs, narcotics, powerful drugs, antipsychotics, therapeutic drugs, etc.), compounding changes, excipient drugs, precautions, types of drug containers (ampoules, vials), capacity of drugs per container (predetermined amount), and information such as the weight of the chemical container. The drug ID is an identification code such as YJ code, JAN code, or RSS code.

The operation display unit 12 includes a display unit such as a liquid crystal display or an organic EL display for displaying various information according to control instructions from the co-infusion control unit 11, and a user interface for inputting various information to the co-infusion control unit 11. It is an example of the 2nd display part provided with the operation part operated by. From the perspective of the operator, the size of the display screen of the display section of the operation display section 12 is larger than the size of the display screen of the terminal display section 162 of the wearable terminal 16, which will be described later.

Specifically, the operation unit of the operation display unit 12 is a touch panel that receives touch operations on various operation screens displayed on the display unit. Note that the operation display unit 12 may be a tablet terminal or the like. Further, the operation unit may include a keyboard and a mouse (pointing device) for receiving input operations on various operation screens displayed on the display unit. Furthermore, the operation unit may include a voice input device that receives input of various information by voice recognition.

The first reading unit 13 is a code reading device capable of reading code information such as a one-dimensional code or a two-dimensional code printed on a prescription or the like corresponding to the preparation data. The code information includes identification information for identifying the preparation data. The code information read by the first reading unit 13 is input to the mixed injection control unit 11 . Then, the co-infusion control unit 11 specifies the preparation data to be the target of the current co-infusion work based on the code information read from the recipe using the first reading unit 13 . Specifically, the co-infusion control unit 11 reads the identification information of the preparation data from the code information, and selects the preparation data corresponding to the identification information from the data storage unit 111 of the storage unit 113 . The co-infusion control unit 11 may acquire the preparation data from the code information.

The printer 14 is used by the mixed injection control unit 11 to print various information. For example, it is used for printing the prescription corresponding to the preparation data executed by the co-infusion control unit 11, or printing the history of the co-infusion work executed according to the preparation data.

The foot switch section 15 is an operation section for an operator to perform an operation input to the co-infusion control section 11 during execution of the co-infusion work. The footswitch unit 15 includes a first footswitch 151 , a second footswitch 152 and a third footswitch 153 . The first footswitch 151 and the second footswitch 152 are used for selecting an item to be operated, and the third footswitch 153 is used for determining an item to be operated.

As shown in FIGS. 1 and 4, the wearable terminal 16 includes a terminal control section 161, a terminal display section 162, an imaging section 163, an operation button 164, a speaker 165, a microphone 166, and the like. For example, the wearable terminal 16 is a wearable glass manufactured by WestUnitis Co., Ltd. with a product name of “InfoLinker (registered trademark)” and a model number of “WUZ-01A-NB01”. In addition, the wearable terminal 16 can communicate with the co-infusion control unit 11 according to a wireless LAN standard such as Wi-Fi (registered trademark) or a short-range wireless communication standard such as Bluetooth (registered trademark). The wearable terminal 16 is provided with a rechargeable secondary battery that is detachable from the wearable terminal 16, and the wearable terminal 16 is operated by power supplied from the secondary battery.

The wearable terminal 16 is a terminal that can be worn by an operator. Specifically, as shown in FIG. 4, the wearable terminal 16 is attachable to and detachable from eyeglasses worn by a worker by a detachable member (not shown), and is a one-eyed type that the worker visually recognizes with one eye. It's smart glasses. It should be noted that the wearable terminal 16 may be configured to be mounted directly on the head of the operator via an attachment (not shown). Also, the wearable terminal 16 may be a so-called head-mounted display or the like integrally configured with glasses. Furthermore, the wearable terminal 16 may be a device such as a smart watch or a smartphone that can be easily carried by the worker and allows the worker to check the displayed information as necessary.

The terminal control unit 161 has a CPU 171, a RAM 172, a storage unit 173, and the like. The CPU 171 is a processor that executes various kinds of arithmetic processing. The RAM 172 is a volatile storage unit, and is used as a temporary storage memory (work area) for various processes executed by the CPU. The storage unit 173 is a non-volatile storage unit such as an EEPROM (registered trademark) that stores information such as control programs for causing the CPU 171 to execute various processes. The terminal control unit 161 uses the CPU 171 and the RAM 172 to execute various processes according to various control programs pre-stored in the storage unit 173 . The storage unit 173 also stores layout information and image data of various display screens displayed on the terminal display unit 162 in a display control process (see FIG. 7) described later.

The terminal display section 162 is an example of a first display section having a small display capable of displaying various information under the control of the terminal control section 161 . The operator can visually recognize the information displayed by the terminal display section 162 by directly looking into the terminal display section 162 . For example, the terminal display unit 162 displays information so that the operator feels as if a display screen corresponding to several inches is displayed several tens of centimeters ahead. Further, when the wearable terminal 16 is used together with eyeglasses, it is also conceivable as another embodiment that the terminal display unit 162 has a microdisplay for projecting information onto the lenses of the eyeglasses or the like.

The photographing unit 163 is a digital camera capable of photographing at the same angle of view as the viewpoint of the worker wearing the wearable terminal 16 . The image or video imaged by the imaging unit 163 is temporarily stored in the storage unit 173 of the terminal control unit 161 and transmitted to the co-infusion control unit 11 .

In the co-infusion support system 1, instead of the first reading unit 13 and the second reading unit 21, the terminal control unit 161 uses the imaging unit 163 to capture code information such as a medicine container or a prescription. It is also conceivable to have a reading function. Accordingly, one or both of the first reading section 13 and the second reading section 21 can be omitted.

The terminal operation unit 164 includes various operation buttons such as a power button for the operator to directly operate the wearable terminal 16 . The speaker 165 is used to reproduce sound based on preset guidance message data. The microphone 166 converts an input voice into a voice signal and inputs the voice signal to the terminal controller 161 . It is conceivable that an earphone terminal to which an earphone or a speaker can be attached is provided instead of the speaker 165, or a microphone terminal to which a microphone can be attached is provided instead of the microphone 166.

By the way, in the co-infusion support system 1 configured in this way, when a large amount of information is displayed on the display device such as the operation display unit 12 and the terminal display unit 162 as information necessary for the co-infusion work, the operator It is necessary to organize information while selecting necessary information and unnecessary information for each work process included in co-infusion work, which may reduce work efficiency. On the other hand, the co-infusion support system 1 according to the present embodiment can improve the working efficiency of the co-infusion work.

In the mixed injection work, for example, a chemical authentication process, a tare process, a solution extraction process, a solution measurement process, a solution photographing process, a dissolution process, a chemical solution extraction process, a chemical solution measurement process, a chemical solution photographing process, and the co-infusion process are selected and executed sequentially.

The medicine authentication step is a step for authenticating the medicines used in the co-injection work, and is a step of reading the identification information of the medicines using the second reading unit 21, for example. The taring step is a step for weighing in advance only the weight of equipment such as a syringe to be used in the co-infusion work, and is a step of placing the syringe on the weighing unit 22, for example.

The dissolution extracting step is a step of extracting a required amount of a dissolution such as physiological saline from an infusion bag with a syringe. The solution weighing step is a step of weighing the syringe from which the solution has been extracted, and is a step of placing the syringe on the weighing unit 22 . In the dissolution liquid weighing step, the co-infusion control device 11 calculates the difference between the weight of the syringe placed on the weighing unit 22 and the weight of the syringe set by the tare subtraction as the weight of the dissolution liquid. Weigh as The dissolving step is a step of dissolving the drug when the drug is a powder, and is a step of injecting the dissolving liquid drawn out with the syringe into the drug container.

The dissolution liquid photographing step is a process for photographing the syringe from which the dissolution liquid has been extracted by the photographing unit 163 . The chemical extracting step is a step of extracting a necessary amount of the chemical from the chemical container with a syringe. The medicinal solution weighing step is a step of weighing the syringe from which the medicinal solution has been extracted, and is a step of placing the syringe on the weighing unit 22 . Also in the medicinal solution weighing process, the co-infusion control device 11 uses the difference between the weight of the syringe placed on the weighing unit 22 and the weight of the syringe set by the tare subtraction as the weight of the medicinal solution. Weigh. The medicinal solution photographing step is a step for photographing the syringe from which the medicinal solution has been extracted by the photographing unit 163 . The mixed injection step is a step of injecting the drug solution in the syringe into the infusion bag.

[Co-injection support processing]
Hereinafter, the co-infusion support processing executed by the co-infusion control unit 11 in the co-infusion support system 1 will be described with reference to FIG. In the co-infusion support process, for example, after logging in to the co-infusion support system 1 by using the operation display unit 12 to input one's own ID and password, an operation to start the co-infusion work was performed. is executed if

<Step S11>
In step S11, the co-infusion control unit 11 determines whether or not the preparation data for the co-infusion work has been selected. Specifically, when the identification information of the preparation data is read by the first reading section 13, the co-infusion control section 11 determines that the preparation data corresponding to the identification information has been selected. Note that it may be determined that the preparation data has been selected when any one of the unadjusted preparation data is selected on the preparation data selection screen displayed on the operation display unit 12 . Here, if it is determined that the preparation data has been selected (S11: Yes), the process proceeds to step S12, and if the preparation data has not been selected (S11: No), the process waits in step S11. . If the preparation data corresponding to the identification information read by the first reading unit 13 is not stored in the storage unit 113, or if the preparation data has already been prepared, an error is reported.

<Step S12>
In step S12, the co-infusion control unit 11 causes the operation display unit 12 to display the preparation data selected in step S11 as the target of the co-infusion work. Here, FIG. 6A is a diagram showing an example of the co-infusion support screen D1 on which the contents of the preparation data are displayed. As shown in FIG. 6A, on the co-infusion support screen D1, the operator name (pharmacist name), inspector name, clinical department, ward, dosing start date, doctor name, patient name (patient ID ), age, sex, prescription content, etc. are displayed. Further, the weighing result by the weighing unit 22 is displayed on the co-infusion support screen D1. The co-infusion control unit 11 also transmits the weighing result of the weighing unit 22 to the wearable terminal 16, and the weighing result is displayed on the terminal display unit 162 by the terminal control unit 161 as necessary. be done.

<Step S13>
In step S13, the co-infusion control unit 11 causes the operation display unit 12 and the terminal display unit 162 to sequentially display information on each work process included in the co-infusion work of drugs to be executed based on the preparation data. Specifically, the co-infusion control unit 11 causes the operation display unit 12 to display information on the work process, and transmits a request to display the work process to the wearable terminal 16 . The work process display request includes information such as the contents of the work process, the amount of work, and the work target. Accordingly, in the wearable terminal 16 , the terminal control section 161 displays the work process information on the terminal display section 162 . As will be described later, the information on the work process sequentially displayed on the terminal display unit 162 by the terminal control unit 161 is the work process to be performed next among the plurality of work processes included in the co-infusion work. This information is necessary only for the work process, and is information in which the contents of the work process, the work amount, and the work target are simplified. Further, instead of step S13, information on the current work process of the co-infusion work may be displayed on the terminal display unit 162 in each of steps S15, S17, S19, S21, and S23.

For example, each time the step S13 is executed, the co-infusion control unit 11 performs , the liquid medicine extracting process, the liquid medicine weighing process, the liquid medicine photographing process, and the co-injection process. The information on the work process includes, for example, the content of the work process (type of work process), work amount (sampling amount, injection amount), and work target (chemical, solution, syringe identification information). However, in the co-infusion support system 1, the information on the work process displayed on the terminal display unit 162 is simplified compared to the information on the work process displayed on the operation display unit 12, as will be described later. ing.

Here, a case will be described where the co-infusion control unit 11 causes the terminal display unit 162 to display information on the work process by transmitting a display request to the wearable terminal 16 . On the other hand, the co-infusion control unit 11 may be configured to directly control the terminal display unit 162 to display information on the work process on the terminal display unit 162 .

Here, FIG. 6B is a diagram showing an example of the main body side display screen D11 displayed on the operation display section 12 in step S13. The main body side display screen D11 is displayed as part of the co-infusion support screen D1, or is displayed as a pop-up superimposed on the co-infusion support screen D1. On the main body display screen D11, a work process area A1, a work amount area A2, and a work target area A3 are displayed as areas showing information on each work process in the co-infusion work. Further, on the main body display screen D11, an operation display area A4 in which currently operable operation items are displayed, and the title of the content of the work process displayed on the main body display screen D11 are displayed in character strings. A status area A5 is displayed.

In the work process area A1, the content of the work process is displayed by a character string indicating the content of the work process. In the work amount area A2, numerical values and units such as the number of chemicals, the amount of extraction, or the amount of injection are displayed as the amount of work in the work process. In the work target area A3, identification information such as a name or code for specifying a work target to be worked in the work process is displayed. In addition, in the operation display unit 12, as described above, patient information, detailed information of the preparation data, and the like are displayed on the co-infusion support screen D1. Therefore, the operator can also confirm the details of the co-infusion work by referring to the co-infusion support screen D1 of the operation display unit 12, the main body side display screen D11, and the like.

<Step S14>
In step S14, the mixed injection control unit 11 determines whether or not the current work process is the drug authentication process. Here, if it is determined that the current work process is the chemical authentication process (S14: Yes), the process proceeds to step S15, and if it is determined that the current work process is not the chemical authentication process (S14 : No), the process proceeds to step S16.

<Step S15>
In step S15, the co-injection control unit 11 executes a chemical authentication process for judging the suitability of the chemicals used in the co-injection work. Specifically, the co-infusion control unit 11 waits for reading of the identification information of the medicine by the second reading unit 21, and when the identification information of the medicine is read, the identification information of the medicine is the current It is verified whether or not it matches the identification information of the drug in the preparation data to be read in the drug authentication process. Then, the co-infusion control unit 11 shifts the process to step S16 when the collation result of the identification information of the medicine is matched. In addition, the co-injection control unit 11 notifies an error and repeats the step S15 when the collation result of the identification information of the medicine is inconsistent.

<Step S16>
In step S16, the co-infusion control unit 11 determines whether or not the current work process is the tare process. Here, if it is determined that the current work process is the tare subtraction process (S16: Yes), the process proceeds to step S17, and if it is determined that the current work process is not the tare subtraction process (S16). : No), the process proceeds to step S18.

<Step S17>
In step S17, the co-infusion control unit 11 performs a tare subtraction process for setting the weight of the syringe used in the co-infusion work. Specifically, the mixed injection control unit 11 waits for the placement of the syringe on the weighing unit 22 and the stabilization of the weighed value by the weighing unit 22, and when the weighed value is stabilized, the mixed injection control unit 11 changes the weighed value to the above This is stored in the storage unit 113 as the tare weight of the syringe, and the process proceeds to step S18.

<Step S18>
In step S18, the co-infusion control unit 11 determines whether or not the current work process is a weighing process such as the solution weighing process or the drug weighing process. Here, if it is determined that the current work process is the weighing process (S18: Yes), the process proceeds to step S19, and if it is determined that the current work process is not the weighing process (S18: No). ), the process proceeds to step S19.

<Step S19>
In step S19, the co-infusion control unit 11 executes processing for supporting the weighing process. Specifically, the co-infusion control unit 11 waits for the placement of the object to be weighed on the weighing unit 22 and the stabilization of the weighed value (hereinafter referred to as the “measured weighed value”) by the weighing unit 22, When the measured value is stabilized, it is determined whether or not the difference between the measured measured value and the target value of the object to be weighed is within a preset error range. Then, when the co-infusion control unit 11 determines that the difference between the actual measurement value and the target measurement value is within the error range, the actual measurement value is stored in the storage unit 113 as a measurement result, and processing is performed. to step S20. If the difference between the actually measured weight value and the target weight value is not within the error range, the co-infusion control unit 11 notifies an error and repeats the step S19.

<Step S20>
In step S20, the mixed injection control unit 11 determines whether or not the current work process is an imaging process such as the solution imaging process or the drug imaging process. Here, if it is determined that the current work process is the photographing process (S20: Yes), the process proceeds to step S21, and if it is determined that the current work process is not the photographing process (S20: No) ), the process proceeds to step S22.

<Step S21>
In step S21, the co-infusion control unit 11 executes processing for causing the photographing unit 163 of the wearable terminal 16 to take a photograph. Specifically, the co-infusion control unit 11 waits for a photographing operation by the photographing unit 163 using the foot switch unit 15, and transmits a photographing request to the wearable terminal 16 when the photographing operation is performed. . As a result, in the wearable terminal 16 , the photographing unit 163 is controlled by the terminal control unit 161 , photographing is performed by the photographing unit 163 , and the photographed image is transmitted to the mixed injection control unit 11 . Then, after the photographed image is displayed on the operation display unit 12, the co-infusion control unit 11 associates the photographed image with the preparation data when the confirmation operation is performed by the operator, and the storage unit 113 as history data. In addition, when the operator performs a re-imaging operation or the like, the co-infusion control unit 11 re-transmits the imaging request to the wearable terminal 16 to re-execute imaging by the imaging unit 163. is also possible.

<Step S22>
In step S22, the co-infusion control unit 11 determines whether or not the current work process is another work process such as the dissolution liquid withdrawal process, the dissolution process, the chemical liquid withdrawal process, and the co-infusion process. . Here, if it is determined that the current work process is the other work process (S22: Yes), the process proceeds to step S23, and it is determined that the current work process is not the other work process. Then (S22: No), the process proceeds to step S13.

<Step S23>
In step S23, the co-injection control unit 11 executes a confirmation process for receiving a confirmation operation for information on the other work process. Specifically, the co-infusion control unit 11 waits for confirmation operation of the work process, and when the confirmation operation is performed, the process proceeds to step S24. The confirming operation is performed by the operator using the operation display section 12 or the foot switch section 15 .

<Step S24>
In step S24, the co-infusion control unit 11 determines whether or not all work steps of the co-infusion work based on the preparation data have been completed. Here, if it is determined that all the work processes have not been completed (S24: No), the process proceeds to step S13 and the same process is executed for the next work process. When it is determined that all the work steps have been completed (S24: Yes), the series of co-infusion support processes for the preparation data is completed, and the process returns to step S11.

As described above, in the co-infusion support process, the work steps necessary for the co-infusion work are sequentially displayed based on the preparation data, so that the operator can proceed with the work steps in order according to the display. Then, in the co-infusion control system 1, as described below, the display on the terminal display unit 162 of the wearable terminal 16 that the worker refers to when the co-infusion work by the worker is supported by the co-infusion support process Unnecessary information has been removed from the screen.

[Display control processing]
Next, the display control processing executed by the terminal control section 161 of the wearable terminal 16 will be described with reference to FIG. The display control process is executed, for example, when the wearable terminal 16 is powered on and the mixed injection control section 11 is powered on. The display control process may be executed by the mixed injection control section 11 .

<Step S31>
In step S31, the terminal control unit 161 determines whether or not the co-infusion control unit 11 has requested to display the work process (step S13). Here, if it is determined that the work process display request has been made (S31: Yes), the process proceeds to step S32, and if it is determined that the work process display request has not been made (S31: No). , the process proceeds to step S33.

<Step S32>
In step S32, the terminal control section 161 causes the terminal display section 162 to sequentially display the terminal display screen D2 showing information on each work process included in the co-infusion work in response to the display request for the work process. The work process display request includes information such as the content of the work process, the amount of work, and the work target, as described above. Here, the terminal control unit 161, when displaying information of a predetermined specific work process among the work processes, displays the contents of the work process (type of work process) as the information of the specific work process. ), the work amount, and the work target alone are displayed on the terminal display screen D2 of the terminal display unit 162. FIG. In this embodiment, the specific work processes are the chemical authentication process, the dissolution solution extraction process, the dissolution process, and the chemical solution extraction process.

Further, when the terminal display screen D2 is displayed on the terminal display part 162, the terminal control part 161 reads aloud the work process information displayed on the terminal display screen D2. Here, the terminal control unit 161 when executing the reading processing is an example of the reading processing unit. As a result, the worker can recognize the information of the work process not only visually but also aurally, thereby suppressing human error in the work process. The work process information may be read aloud by voice of any one or more of the content of the work process, the amount of work, and the work target in the information of the work process. For example, in the storage unit 173 of the terminal control unit 161, voice data in which the content of the work process is read out corresponding to each content of the work process is stored in advance. The audio data corresponding to the content of the work process is reproduced by the speaker 165 . In addition, reading out the information of the work process by the voice may be omitted.

Here, FIG. 8 is a diagram showing an example of the terminal display screen D2 when the work process is the medicine authentication process. The chemical authentication process is an example of a specific work process in the present invention. As shown in FIG. 8, the terminal display screen D2 displays only a work process area A11, a work amount area A12, and a work target area A13 as areas showing information on each work process in the mixed injection work. there is Further, on the terminal display screen D2, an operation display area A14 and a status area A15 are displayed separately from the work process information. 6A and 8, the amount of information on the work process displayed on the terminal display unit 162 is larger than the amount of information on the work process displayed on the operation display unit 12. As shown in FIGS. less.

On the terminal display screen D2, the work process area A11 and the work amount area A12 are displayed side by side in the upper stage, and the work target area A13 is displayed in the lower stage thereof. The background colors of the work process area A11, the work amount area A12, and the work target area A13 are displayed in preset colors different from each other. The operation display area A14 is displayed below the work area A13, and the status area A15 is displayed on the left side of the work process area A11 and the work area A13.

In the work process area A11, a pictogram showing the content of the work process by illustration or the like is displayed as the content of the work process. Specifically, the storage unit 173 of the wearable terminal 16 stores image data of pictograms preset corresponding to each content of the work process. Then, the terminal control unit 161 reads the image data of the pictogram corresponding to the content of the work process from the storage unit 173 in response to the display request of the work process, and displays the pictogram in the work process area A11. . Accordingly, the worker can intuitively recognize the content of the work process by referring to the work process area A11.

In the work amount area A12, numerical values and units such as the number of chemicals, the amount of extraction, or the amount of injection are displayed as the amount of work in the work process. Specifically, the amount of work is the number of chemicals that need to be certified in the chemical authentication step, the extraction amount in the solution extraction step or the chemical extraction step, and the injection amount in the dissolution step.

In the work target area A13, identification information such as a name or code for specifying a work target to be worked in the work process is displayed. More specifically, when the work target is a drug, the name or abbreviation of the drug is displayed as the identification information, and when the work target is a syringe, the name or abbreviation of the syringe is displayed as the identification information. Information is displayed, and when the work target is a solution, the name or abbreviated name of the solution is displayed as the identification information. In particular, in the wearable terminal 16, the identification information of the work target displayed in the work target area A13 is set in advance within a range equal to or larger than a preset character size. If the identification information cannot be displayed in the work area A13 in a character size larger than the character size, the identification information may be scroll-displayed in the work area A13.

In this way, on the terminal display screen D2, only the content of the work process, the amount of work, and the work target are displayed as the information of the work process, and the information necessary for carrying out the work process is selected. Since it is not necessary, the work efficiency of the co-infusion work by the operator is improved.

In the terminal display screen D2, the operation display area A14 displays currently operable operation items. Specifically, in the operation display area A14, an operation area A141 indicating operation items accepted by the co-infusion control unit 11 when the third foot switch 153 is operated is displayed. Further, in the operation display area A14, an operation area A142 indicating an operation item that is moved to the operation area A141 and displayed when the first foot switch 151 is operated, and the second foot switch 152 are operated. An operation area A143 showing operation items displayed in the operation area A141 when the operation is performed is displayed.

For example, in the example shown in FIG. 8, a state is shown in which the operation content of "return" is assigned to the operation area A142, "skip" is assigned to the operation area A143, and "authentication" is assigned to the operation area A141. . Then, the mixed injection control unit 11 displays "return" in the operation area A141 when the first foot switch 151 is operated, and displays "return" in the operation area A141 when the second foot switch 152 is operated. Display "Skip". On the other hand, when the third foot switch 153 is operated, the mixed injection control section 11 executes processing corresponding to the operation content of "authentication" displayed in the operation area A141. Specifically, when it is the chemical authentication step, the chemical authentication process (S15) is started.

In the status area A15, a color preset corresponding to the content of the work process displayed on the terminal display screen D2 is displayed. Accordingly, the worker can easily recognize the content of the work process by referring to the status area A15. Note that the color displayed in the status area A15 is not limited to being different for each content of the work process, and may be a different color for each group preset for the content of the work process. For example, the contents of the work processes may be classified into a group of work processes involving extraction or injection, a group of work processes involving weighing, a group of work processes involving photography, and the like.

Further, in step S32, the terminal control unit 161 causes the terminal display screen D2 to be displayed on the terminal display unit 162, and at the same time, the work process information displayed on the terminal display screen D2 can be read aloud. good. As a result, the worker can recognize the information of the work process not only visually but also aurally, thereby suppressing human error in the work process. The work process information may be read aloud by voice of any one or more of the content of the work process, the amount of work, and the work target in the information of the work process. For example, in the storage unit 173 of the terminal control unit 161, voice data in which the content of the work process is read out corresponding to each content of the work process is stored in advance. The audio data corresponding to the content of the work process is reproduced by the speaker 165 . In addition, reading out the information of the work process by the voice may be omitted.

<Step S33>
In step S33, the terminal control section 161 determines whether or not the photographing request of the photographing section 163 has been made. For example, the co-infusion control unit 11, when the third foot switch 153 of the foot switch unit 15 is operated in a state in which "shooting" is displayed in the operation area A141 of the terminal display screen D2, The photographing request is transmitted to the terminal control section 161 .

<Step S34>
In step S<b>34 , the terminal control section 161 executes photography by the photography section 163 and transmits the photographed image photographed by the photography section 163 to the co-infusion control section 11 . Thereby, the co-infusion control unit 11 can store the photographed image as history data in the storage unit 113 in association with the preparation data corresponding to the co-infusion work.

As described above, in the co-infusion support system 1, the operator refers to the terminal display screen D2 displayed on the terminal display unit 162 of the wearable terminal 16 to execute each work process of the co-infusion work. It is possible to In particular, on the terminal display screen D2, only the content of the work process, the amount of work, and the work target are extracted and displayed as information on each work process of the co-infusion work. Therefore, the operator does not need to select necessary information and unnecessary information for each work process included in the co-infusion work, thereby improving the work efficiency of the co-infusion work.

[Display example corresponding to each work process]
Hereinafter, display examples of the terminal display screen D2 when each work process included in the co-infusion work is executed will be described with reference to FIGS. 9 to 24. FIG. 9 to 24, the terminal display screen D2 displayed on the terminal display section 162 is shown on the right side. 9 to 24, the main body display screen D11 popped up on the co-infusion support screen D1 in the operation display unit 12 when the terminal display screen D2 is displayed is shown on the left side. The size relationship between the main body display screen D11 and the terminal display screen D2 in FIGS. 9 to 24 is not limited to the ratios shown in FIGS.

<Chemical certification process>
9 and 10 are diagrams showing display examples corresponding to the drug authentication process.

As shown in FIG. 9, on the main body side display screen D11, a character string "Please authenticate" is displayed in the work process area A1 as the contents of the work process. Further, in the work amount area A2, a character string of "number: 0/1" is displayed as the work amount. Further, in the work target area A3, a character string of "Alimta (registered trademark)" for injection 500 mg" is displayed as the work target.

On the other hand, as shown in FIG. 9, in the terminal display screen D2, the work process area A11 is set in advance corresponding to the drug authentication process, and the identification information of the drug is entered using the second reading unit 21. A pictogram is displayed to suggest the operation of reading from a barcode. A character string of "0/1" is displayed in the work amount area A12 as the work amount. Further, in the work target area A13, a character string of "500 mg Alim", which is an abbreviation of the drug "500 mg for Alimta injection", which is the work target, is displayed.

When other chemicals are also used in the co-injection work, information corresponding to the chemical authentication step is similarly displayed on the main body display screen D11 and the terminal display screen D2 for the other chemicals. be. For example, in FIG. 10, in the main body display screen D11 and the terminal display screen D2, as the information of the drug authentication process for the other drug, the content of the work process is the drug authentication process, and the work target is Alimta. It is indicated that it is 100 mg for injection and that the amount of work is three.

<Tare subtraction process>
Here, FIG. 11 is a diagram showing a display example corresponding to the tare subtraction process.

As shown in FIG. 11, on the display screen D11 on the main body side, a character string "Please tare the empty syringe" is displayed in the work process area A1 as the content of the work process. Further, in the work target area A3, a character string "50 mL syringe-1" is displayed as the work target.

On the other hand, as shown in FIG. 11, on the terminal display screen D2, in the work process area A11, a balance is set in advance corresponding to the tare process and suggests a weighing operation included in the tare process. A pictogram showing the movement of the needle is displayed. Further, on the terminal display screen D2, instead of the work target area A13, a work target area A131 indicating the identification information of the work target of the tare subtraction process and the measured value actually measured by the weighing unit 22 are displayed. A measurement area A130 including an actual measurement area A132 is displayed. Furthermore, in the weighing area A130, a stability display area A16 is displayed to indicate whether or not the weighing state by the weighing unit 22 has stabilized. For example, when the weighing state by the weighing unit 22 is not stable, the stability display area A16 is displayed in red, and when it is stable, the stability display area A16 is displayed in blue.

<Dissolved liquid extraction process>
Here, FIG. 12 is a diagram showing a display example corresponding to the dissolution liquid withdrawal step.

As shown in FIG. 12, on the display screen D11 on the main body side, a character string "Drain the dissolving liquid" is displayed in the work process area A1 as the content of the work process. Further, in the work amount area A2, a character string of "dosage: 32.6 mL" is displayed as the work amount. Further, in the work target area A3, a character string of "physiological saline 500 ml" is displayed as the work target.

On the other hand, as shown in FIG. 12, in the terminal display screen D2, in the work process area A11, the piston of the syringe that is set in advance corresponding to the dissolution liquid withdrawal process and included in the dissolution liquid withdrawal process is displayed. A pictogram is displayed to suggest the action of pulling out the solution. Further, in the work amount area A12, a character string of "excluded 32.6 mL" is displayed as the work amount. Further, in the work target area A13, a character string of "500 ml of normal saline", which is an abbreviation of the work target drug "physiological saline 500 ml", is displayed.

<Dissolving liquid weighing process>
Here, FIG. 13 is a diagram showing a display example corresponding to the dissolution liquid measuring step.

As shown in FIG. 13, on the display screen D11 on the main body side, a character string "Please measure the solution" is displayed in the work process area A1 as the content of the work process. Further, in the work amount area A2, a character string of "dosage: 32.6 mL" is displayed as the work amount. Further, in the work target area A3, a character string of "physiological saline 500 ml" is displayed as the work target.

On the other hand, as shown in FIG. 13, in the terminal display screen D2, in the working process area A11, the solution is set in advance corresponding to the solution measuring process, and the solution included in the solution measuring process is inhaled. A pictogram is displayed to suggest the metering action of the syringe being applied. Further, on the terminal display screen D2, instead of the work amount area A12, a balance area A121 is displayed in which the target weight value and the actually measured weight value are displayed in a visually recognizable manner. Further, on the terminal display screen D2, instead of the work target area A13, a target area A133 showing the target weighed value of the work target of the solution weighing step and the actually measured weighed value by the weighing section 22 are displayed. A measurement area A130 including an actual measurement area A132 is displayed. In the weighing area A130, the stable display area A16 indicating whether or not the weighing state by the weighing unit 22 is stable is also displayed.

Here, as shown in FIG. 13, in the balance area A121, a plurality of scales are displayed which are formed at predetermined intervals and are formed upward to the right. A scale corresponding to the weighing value is displayed. It should be noted that the range of weights assigned between each of the scales may decrease toward the center.

The scale corresponding to the target metric value is displayed in a manner such as a color different from that of the other scales so as to be distinguishable from the other scales. In addition, the terminal control unit 161 acquires the actual measurement value by the weighing unit 22 from the mixed injection control unit 11 in real time, and in the balance area A121, the actual measurement value display. Specifically, in the balance area A121, the shorter the scale on the left side, the smaller the measured value, and the longer the scale on the right side, the larger the measured value. As a result, the operator can intuitively recognize whether or not the target weighed value and the actually measured weighed value match in the balance area A121, and if they do not match, the amount of error can be determined. It is possible to grasp intuitively.

The terminal control unit 161 also changes the background color of the actual measurement area A132 depending on whether or not the difference between the actual measurement weight value and the target weight value is within a preset error range in the measurement area A131. It is conceivable to change the display mode such as Specifically, when the difference is not within the error range, the terminal control unit 161 displays the background color of the actual measurement area A132 in a first specific color such as red, and the difference is within the error range. , the background color of the actual measurement area A132 is displayed in a second specific color such as white or blue that is different from the first specific color.

<Solution photographing process>
Here, FIG. 14 is a diagram showing a display example corresponding to the solution photographing process.

As shown in FIG. 14, on the display screen D11 on the main body side, a character string "Please take an image" is displayed in the work process area A1 as the contents of the work process. Further, in the work target area A3, a character string "physiological saline 500 ml" is displayed as the work target.

On the other hand, as shown in FIG. 14, in the terminal display screen D2, in the work process area A11, the image captured by the imaging unit 163, which is set in advance corresponding to the solution imaging process and included in the solution imaging process, is displayed. A pictogram showing a camera image suggesting a shooting operation is displayed. Further, in the work target area A13, a character string of "500 ml saline", which is an abbreviation of the work target drug "physiological saline 500 ml", is displayed.

<Dissolution process>
15 to 18 are diagrams showing display examples corresponding to the dissolving step.

As shown in FIG. 15, on the display screen D11 on the main body side, a character string "Please dissolve" is displayed in the work process area A1 as the content of the work process. In the work amount area A2, a character string of "dissolution amount: 20 mL" is displayed as the work amount. Further, in the work target area A3, a character string "500 mg for Alimta injection" is displayed as the work target.

On the other hand, as shown in FIG. 15, in the terminal display screen D2, in the work process area A11, the dissolution liquid in the syringe included in the dissolution process is preset in the work process area A11, and the dissolution liquid in the syringe included in the dissolution process is displayed as the medicine. A pictogram is displayed to suggest the action of filling the container. Further, in the work amount area A12, a character string of "input 20 mL" is displayed as the work amount. Further, in the work target area A13, a character string of "500 mg Alim", which is an abbreviation of the drug "500 mg for Alimta injection", which is the work target, is displayed.

When other chemicals are also used in the co-injection work, information corresponding to the dissolution step is similarly displayed on the main body display screen D11 and the terminal display screen D2 for the other chemicals as well. . For example, in FIGS. 16 to 18, as information on the dissolution process for the other medicine, the content of the work process is a dissolution process, and the work target is It is indicated that it is 100 mg for Alimta injection and that the working volume is 4.2 mL.

By the way, as shown in FIGS. 16 to 18, when the dissolution step is continuously executed a plurality of times for a plurality of drug containers containing the same drug, the same terminal display screen D2 will be displayed several times in succession. Specifically, in the examples shown in FIGS. 16 to 18, 4.2 ml of the dissolution liquid in the syringe is injected into each of three drug containers corresponding to "100 mg alim" and dissolved. . On the other hand, as shown in FIGS. 16 to 18, when the same work process such as the dissolution process is repeated multiple times for the same drug, the terminal control unit 161 displays the progress status of the work process. is displayed on the terminal display screen D2. In the progress bar A17, the display mode such as the color of each of the partial regions divided by the number of the work processes repeatedly executed in the longitudinal direction is sequentially changed each time the work process is completed. Accordingly, the worker can easily recognize the progress of the current work process for the same work process corresponding to the same chemical by referring to the progress bar A17. The display of the progress bar A17 may be omitted.

19A to 19C, instead of the progress bar A17 shown in FIGS. 16 to 18, the terminal control unit 161 clearly indicates each partial area divided by the number of work steps. can be considered. For example, in the examples shown in FIGS. 19A-19C, line segments are formed at the boundaries of each of the partial regions. This allows the operator to more accurately grasp the number of partial areas and the progress.

<Chemical Solution Sampling Process>
Here, FIGS. 20 and 21 are diagrams showing display examples corresponding to the liquid medicine extracting process.

As shown in FIG. 20, on the display screen D11 on the main body side, a character string "Please remove" is displayed in the work process area A1 as the content of the work process. Further, in the work amount area A2, a character string "dosage: 20 mL" is displayed as the work amount. Further, in the work target area A3, a character string "500 mg for Alimta injection" is displayed as the work target.

On the other hand, as shown in FIG. 20, in the terminal display screen D2, in the work process area A11, the piston of the syringe, which is set in advance corresponding to the liquid medicine extracting process and included in the liquid medicine extracting process, is pulled. A pictogram is displayed to suggest an operation of extracting the chemical solution from the chemical container. Further, in the work amount area A12, a character string of "excluded 20 mL" is displayed as the work amount. Further, in the work target area A13, a character string of "500 mg Alim", which is an abbreviation of the drug "500 mg for Alimta injection", which is the work target, is displayed.

Further, when other chemicals are also used in the co-injection work, information corresponding to the liquid medicine extracting step is similarly displayed on the main body display screen D11 and the terminal display screen D2 for the other chemicals. be. For example, in FIG. 21, in the main body display screen D11 and the terminal display screen D2, as the information of the dissolution process for the other drug, the content of the work process is the dissolution process, and the work object is for Alimta injection. It is 100 mg and it is indicated that the working volume is 12 mL. In the example shown in FIG. 20, "100 mg for Alimta injection", which is the object of the liquid medicine extraction step, is extracted from the three medicine containers, but as shown in FIG. On the terminal display screen D2, the total amount of the amount of the liquid medicine withdrawn from the three chemical containers is displayed in the work amount area A12.

<Chemical liquid weighing process>
Here, FIG. 22 is a diagram showing a display example corresponding to the chemical liquid measuring step.

As shown in FIG. 22, on the display screen D11 on the main body side, a character string "Please measure" is displayed in the work process area A1 as the content of the work process. Further, in the work amount area A2, a character string "dosage: 32 mL" is displayed as the work amount. Further, in the work target area A3, a character string "for Alimta injection" is displayed as the work target.

On the other hand, as shown in FIG. 22, in the terminal display screen D2, in the work process area A11, the liquid medicine set in advance corresponding to the liquid medicine measuring process and the liquid medicine included in the liquid medicine measuring process is inhaled. A pictogram is displayed to suggest the metering action of the syringe. Further, on the terminal display screen D2, the balance area A121 is displayed instead of the work amount area A12, as in the solution weighing step. Further, on the terminal display screen D2, the measurement area A130 is displayed instead of the work target area A13, as in the solution measurement step. In the weighing area A130, the stable display area A16 indicating whether or not the weighing state by the weighing unit 22 is stable is also displayed. Further, as described above, the terminal control unit 161 determines whether or not the difference between the actually measured weight value and the target weight value is within a preset error range in the weight area A131. It is conceivable to change the display mode such as the background color of the area A132.

<Chemical solution photography process>
Here, FIG. 23 is a diagram showing a display example corresponding to the chemical imaging process.

As shown in FIG. 23, on the display screen D11 on the main body side, a character string "Please take an image" is displayed in the work process area A1 as the content of the work process. Further, in the work target area A3, a character string "50 mL syringe-1" is displayed as the work target.

On the other hand, as shown in FIG. 23, in the terminal display screen D2, in the work process area A11, there is an imaging operation by the imaging unit 163 that is set in advance corresponding to the chemical imaging process and included in the chemical imaging process. A pictogram is displayed showing a camera image suggesting that Further, in the work target area A13, a character string of the work target drug "50 mL syringe-1" is displayed.

<Co-injection process>
Here, FIG. 24 is a diagram showing a display example corresponding to the mixed injection process.

As shown in FIG. 24, on the display screen D11 on the main body side, a character string of "please co-inject" is displayed in the work process area A1 as the content of the work process. On the other hand, as shown in FIG. 24, in the terminal display screen D2, in the work process area A11, the drug solution in the syringe included in the co-infusion process is preset in the work process area A11, and the drug solution in the syringe included in the co-infusion process is displayed in the infusion bag. A pictogram is displayed to suggest the operation of injecting into.

As described above, in the co-infusion support system 1 according to the present embodiment, only the information required for the co-infusion work is aggregated and displayed on the terminal display screen D2 of the terminal display unit 162 of the wearable terminal 16. . Therefore, the operator can refer to the terminal display screen D2 to proceed with the co-infusion work efficiently.

In this embodiment, a case has been described in which the information of each work process is displayed in different modes on the main body side display screen D11 and the terminal display screen D2. On the other hand, it is conceivable as another embodiment that the main body side display screen D11 is the same as the terminal display screen D2.

Further, in the present embodiment, only the content of the work process, the amount of work, and the work target are displayed on the terminal display screen D2 as information on the work process of the co-infusion work. On the other hand, the operation display area A14 and the status area A15 are also displayed on the terminal display screen D2.

On the other hand, as shown in FIGS. 25A to 25C, the terminal control unit 161 may display the terminal display screen D2 in which one or both of the operation display area A14 and the status area A15 are omitted. Other embodiments are possible. That is, only the work process area A11, the work amount area A12, and the work target area A13 are displayed on the terminal display screen D2, and the work process area A11, the work amount area A12, and the work target area A13 are displayed on the terminal display screen D2. and that only the operation display area A14 is displayed on the terminal display screen D2, and that only the work process area A11, the work amount area A12, the work target area A13, and the status area A15 are displayed on the terminal display screen D2 It is conceivable that it will be displayed in

Further, the terminal control unit 161 may cause at least the work process area A11, the work amount area A12, and the work target area A13 to be sequentially and individually displayed on the terminal display screen D2 at predetermined intervals. Conceivable. Thereby, it is possible to display each of the work process area A11, the work amount area A12, and the work target area A13 in a large size on the terminal display screen D2.

Further, when the terminal control unit 161 displays the terminal display screen D2, the display of the operation display area A14 is omitted, and the mixed injection control unit 11 receives the operation of the foot switch unit 15. In some cases, the operation display area A14 may be temporarily displayed according to the input signal from the co-infusion control unit 11. Furthermore, the terminal control unit 161 causes the status area A15 to be displayed only until a preset time elapses after the terminal display screen D2 is displayed, and thereafter the display of the status area A15 is omitted. It is also conceivable to let

Further, when the terminal control unit 161 displays identification information such as a drug name as the work target in the work target area A13, at least an abbreviated character string obtained by removing the standard from the identification information is displayed. can be considered. For example, when the identification information is "500 mg for Alimta injection", it is conceivable that an abbreviated character string such as "Alimta" or "for Alimta injection" is displayed. In particular, the terminal control unit 161 causes the terminal display unit 162 to display the name of the drug without abbreviation in the drug authentication step for authenticating the drug among the work steps, and displays the name of the drug without omission on the terminal display unit 162. When displaying the chemical name for the work process, it is conceivable to display an abbreviation of the chemical name on the terminal display unit 162 . It is conceivable that the abbreviated characters are displayed in the work target area A13 only when the terminal display screen D2 in which the work amount is displayed in the work amount area A12 is displayed. This prevents erroneous recognition of the number included in the identification information as a standard and the work amount.

[Other functions]
Other functions of the co-infusion support system 1 will be described below. In the co-infusion support system 1, the various functions described here can be switched between valid and invalid in the initial settings of the co-infusion control unit 11 or the wearable terminal 16, or the like.

[Drug image display function]
In the above embodiment, a case has been described in which a character string of identification information such as the drug name is displayed as the work target on the terminal display screen D2. On the other hand, in the wearable terminal 16, the terminal control unit 161 may have a drug image display function for displaying a drug image P1, such as an appearance photograph or an appearance illustration, of the drug as the work target on the terminal display screen D2. Conceivable. In addition, it is desirable that the drug image P1 includes at least identification information that enables identification of the type of the drug.

Specifically, in the wearable terminal 16 , the storage unit 173 stores drug image masters including the drug images P<b>1 corresponding to each drug displayed on the wearable terminal 16 . In the drug image master, the identification information (drug name, drug code, etc.) of each drug and the drug image P1 are associated and stored. Thereby, the terminal control unit 161 can specify the drug image P1 corresponding to the drug from the drug image master based on the identification information of the drug that is the work target.

When the drug image display function is set to be valid, the terminal control unit 161 displays the terminal display screen D2 (for example, 8, etc.), the drug name and the drug image P1 are alternately displayed at predetermined time intervals. Note that the terminal control unit 161 controls the entire terminal display screen D2 to display a state in which the content of the work process, the amount of work, and the work target are displayed, a state in which the drug image is displayed, and a state in which the drug image is displayed. It is also conceivable to switch the state in which the image P1 is displayed. That is, it is conceivable that the drug image P1 is displayed on the entire terminal display screen D2. It is also conceivable that the terminal control unit 161 simultaneously displays the drug name and the drug image P1 on the terminal display screen D2 in the work target area A13.

Thus, according to the medicine image display function, the operator can intuitively recognize the medicine to be worked in the work process by the medicine image P1, thereby improving the working efficiency of the co-infusion work. , it is possible to suppress human error in the co-infusion work.

[Medicine image automatic update function]
By the way, when a new drug is launched as a target drug for the co-injection operation, it is necessary to register the drug image P1 corresponding to the new drug in the drug image master. Also, when the design of the drug container containing the drug is changed, it is necessary to change the drug image P1 corresponding to the drug.

On the other hand, it is conceivable that the co-injection control unit 11 has a drug image automatic update function for automatically updating the drug image P1 based on a preset drug database. The drug database is stored in advance in a server device or the like with which the co-infusion control unit 11 can communicate wirelessly or by wire through the communication network, and the co-infusion control unit 11 acquires the drug database from the server device. It is possible. The server device is, for example, a cloud server provided on the Internet. The drug database may be read from a recording medium such as a CD or DVD by a reading device (not shown) provided in the co-infusion control unit 11 .

Then, the co-injection control unit 11 implements the drug image automatic updating function by executing the following drug image update processing (see FIG. 28) based on the drug database. Here, the mixed injection control unit 11 when executing the drug image update processing is an example of the drug update processing unit. Note that the medicine update process may be executed by the terminal control unit 161 . The co-injection control unit 11 executes the drug image update process, for example, when the power of the co-infusion control unit 11 is turned on, when returning from the power saving mode, or when an arbitrary update start operation is performed. An example of the procedure of the drug image update process will be described below with reference to FIG. 28 .

<Step S41>
In step S41, the co-infusion control unit 11 creates the drug image P1 corresponding to each drug in the drug database based on the identification information of each drug included in the drug master stored in the storage unit 113. Get update date and time. For example, the update date and time are included in the data of the drug image P1 as time stamp information, or stored in the drug database.

<Step S42>
In step S<b>42 , the mixed injection control unit 11 acquires the update date and time of the drug image P<b>1 corresponding to each drug in the drug image master stored in the wearable terminal 16 . For example, the update date and time are included in the data of the drug image P1 as time stamp information, or stored in the drug image master. The drug image master may be stored in the storage section 113 of the mixed injection control section 11 .

<Step S43>
In step S43, the co-injection control unit 11 updates the update date and time of the drug image P1 in the drug database and the update date and time of the drug image P1 in the drug image master for each of the drugs included in the drug master. Compare and detect differences.

<Step S44>
Then, in step S44, the mixed injection control unit 11 updates the drug image master stored in the storage unit 173 of the wearable terminal 16 based on the difference detected in step S43.

Specifically, when a drug that does not exist in the drug image master exists in the drug database, the mixed injection control unit 11 acquires the drug image P1 of the drug from the drug database and sends it to the wearable terminal 16. Send. As a result, in the wearable terminal 16, the terminal control unit 161 registers the drug identification information and the drug image P1 in the drug image master in the storage unit 173 in association with each other. In addition, the co-injection control unit 11 may be configured to be able to register the drug image P1 in the storage unit 173 of the wearable terminal 16 . As a result, the co-infusion support system 1 can automatically cope with new drugs and the like.

Also, when the update date and time of the drug image P1 of the drug existing in the drug image master is before the update date and time of the drug image P1 of the same drug in the drug database, the mixed injection control unit 11 The drug image P<b>1 is acquired from the drug database and transmitted to the wearable terminal 16 . As a result, in the wearable terminal 16, the terminal control unit 161 converts the drug image P1 transmitted from the mixed injection control unit 11 into the drug image P1 corresponding to the drug in the drug image master in the storage unit 173. Update as As a result, the co-injection control unit 11 can automatically cope with a change in the medicine image P1 for the already registered medicine.

Further, when the drug existing in the drug image master does not exist in the drug database, the mixed injection control unit 11 deletes the drug image P1 of the drug from the storage unit 173 of the wearable terminal 16 . As a result, in the wearable terminal 16, the unnecessary drug images P1 are automatically deleted, thereby suppressing the pressure on the storage capacity.

[Setting function]
In the wearable terminal 16, one or more setting items regarding the wearable terminal 16 can be arbitrarily set. The setting items include, for example, the display mode of the terminal display unit 162, the connection destination of the wearable terminal 16, and the like. For example, it is conceivable that the setting of such various setting items is performed according to the operation of the terminal operation unit 164 of the wearable terminal 16 by the operator. Action must be taken. On the other hand, the wearable terminal 16 may have a setting function that allows the operator to set the setting items without using hands, and the setting function will be described below.

Here, the display mode, which is an example of the setting item, will be described. First, it is conceivable that the wearable terminal 16 can be worn by a worker in a state in which the terminal display unit 162 can be viewed with only one of a predetermined right eye or left eye. The operator cannot freely select the right eye or the left eye. On the other hand, the wearable terminal 16 has a right-eye mode in which the worker views the terminal display unit 162 with the right eye and a left-eye mode in which the worker views the terminal display unit 162 with the left eye. It is conceivable that the display mode of the terminal display unit 162 can be arbitrarily switched between the right-eye mode and the left-eye mode. Specifically, when the worker looks at the terminal display unit 162 with his left eye, the worker wears the terminal display unit 162 in the state shown in FIG. When viewed, the wearable terminal 16 is mounted upside down from the state shown in FIG. Therefore, the terminal control section 161 reverses the display screen of the terminal display section 162 in the right-eye mode and the left-eye mode.

Next, the connection destination, which is an example of the setting item, will be described. First, a hospital or a pharmacy where the co-infusion support system 1 is used may be provided with a plurality of the co-infusion support systems 1 . In this case, it is conceivable that which co-infusion support system 1 to use the wearable terminal 16 is fixed in advance, but the co-infusion support system 1 using the wearable terminal 16 can be arbitrarily switched. is desirable. Therefore, it is conceivable that the terminal control unit 161 can arbitrarily set the connection destination of the wearable terminal 16 . Specifically, machine numbers corresponding to a plurality of co-infusion support systems 1 are set in advance, and the connection destination is set by setting the machine number. In addition, in a plurality of the co-infusion support systems 1, it is possible that the co-infusion control unit 11 is common. In this case, instead of the connection destination of the wearable terminal 16, for example, the co-infusion control unit Associations with components such as the foot switch section 15, the second reading section 21, and the weighing section 22 are set as setting items.

The terminal control unit 161 implements the setting function by executing a setting process (see FIG. 29), which will be described later. Here, the terminal control section 161 when executing the setting process is an example of the setting processing section. Here, the terminal control unit 161 executes the setting process when the wearable terminal 16 is activated by turning on the power of the wearable terminal 16 or returning from the power saving mode.

Also, part or all of the setting process may be performed by the co-infusion control unit 11 . In this case, the mixed injection control unit 11 recognizes activation of the wearable terminal 16 based on the activation signal transmitted from the wearable terminal 16 after the wearable terminal 16 is powered on and activated.

An example of the setting process procedure will be described below with reference to FIG.

<Step S51>
First, when the wearable terminal 16 is activated, the terminal control section 161 causes the terminal display section 161 to display a setting screen D3 used for setting the contents of the setting items in step S51. The layout information and image data of the setting screen D3 are stored in the storage section 173. FIG. 30A to 30C are diagrams showing an example of the setting screen D3.

As shown in FIG. 30A, the terminal control section 161 causes the image captured by the photographing section 163 to be displayed on the preview screen P2 on the setting screen D3. In addition, the terminal control unit 161 also displays a message on the setting screen D3 for prompting to copy code information such as a one-dimensional code or a two-dimensional code on the preview screen P2. Further, when the history of the setting items set in the wearable terminal 16 in the past is stored in the storage unit 173, the terminal control unit 161 stores the latest history as the current setting contents of the setting items. is displayed on the setting screen D3. The history of the setting items is stored in the storage unit 113 of the co-infusion control unit 11, and the terminal control unit 161 may read the history from the storage unit 113. In the example shown in FIG. 30A, as the setting contents of the current setting items, it is displayed that the display mode is the right-eye mode and the connection destination is the first machine.

<Step S52>
In step S52, the terminal control unit 161 transitions to a standby state in which reading processing for reading information from code information such as a one-dimensional code or a two-dimensional code captured by the imaging unit 163 can be executed. Here, the code information may be printed on a paper medium (not shown), attached to the safety cabinet 100, or displayed on a tablet terminal (not shown). The one-dimensional code is, for example, a bar code, and the two-dimensional code is, for example, a QR code (registered trademark). Here, the terminal control section 161 when executing the reading process is an example of the reading processing section. Specifically, the terminal control unit 161 reads information from the code information when the code information exists within the imaging range of the imaging unit 163 . That is, the terminal control section 161 can read information from the code information without requiring a photographing operation by the operator.

<Step S53>
In step S53, the terminal control unit 161 starts counting the standby time indicating the duration of the standby state. Specifically, the terminal control unit 161 resets the waiting time to 0 at the timing when step S53 is executed, and starts counting the waiting time.

<Step S54>
In step S54, the terminal control unit 161 determines whether information has been read from the code information by the reading process in the standby state. Here, if it is determined that information has been read from the code information (S54: Yes), the process proceeds to step S541. On the other hand, if it is determined that information has not been read from the code information (S54: No), the process proceeds to step S55. Note that the terminal control unit 161 determines that the information is read only when the information read in the reading process includes predetermined specific information used for setting the setting item, and determines that the information is read. is not included, it is conceivable to ignore the information read in the reading process.

<Step S55>
In step S55, the terminal control unit 161 determines whether or not the standby time for which time measurement was started in step S53 is equal to or longer than a preset upper limit time (for example, 5 seconds or 10 seconds). Here, when it is determined that the standby time is equal to or longer than the upper limit time (S55: Yes), the process proceeds to step S56. If it is determined that the waiting time is not equal to or longer than the upper limit time (S55: No), the process returns to step S54.

In the present embodiment, the upper limit time (corresponding to the first upper limit time) used as a determination index in the first step S55 executed after the wearable terminal 16 is activated, and the steps executed after the second time A case will be described where the upper limit time (corresponding to the second upper limit time) used as the determination index in S55 is the same time, but the upper limit times (first upper limit time, second upper limit time) are different times. good too. That is, the terminal control unit 161 reads information by the reading process within the first upper limit time after the wearable terminal 16 is activated, and even after setting the setting items based on the information, the terminal control unit 161 remains in the standby state. to maintain After that, when the information is read by the reading process at an interval within the second upper limit time set in advance, the terminal control unit 161 sets the content of the setting item based on the information, and waits for the setting item. maintain state. That is, when the information is read by the reading process at intervals within the second upper limit time not only for the second time after the wearable terminal 16 is activated, but also for the third time and thereafter, the contents of the setting items are changed based on the information. Settings will be executed. On the other hand, the terminal control unit 161 cancels the standby state when the information is not read by the reading process before the second upper limit time elapses after the information is read by the previous reading process. For example, if the first upper limit time is set longer than the second upper limit time, the worker can afford to read the code information for the first time after turning on the power of the wearable terminal 16. reduces unnecessary waiting time.

In addition, even if the standby time has not reached the upper limit time or longer in step S55 (S55: No), the terminal control unit 161 sets all of the setting items that can be set in the wearable terminal 16. It is also conceivable as another embodiment to move the process to step S58 when the setting for is executed once.

<Step S541>
On the other hand, if it is determined that information has been read from the code information, then in subsequent step S541, the terminal control unit 161 sets the contents of the setting items based on the information read from the code information, and While maintaining the standby state, the process returns to step S53.

That is, if information is read by the reading process during the period from when the wearable terminal 16 starts to be activated and the wearable terminal 16 transitions to the standby state until the upper limit time elapses, the terminal control unit 161 reads the information. The contents of the setting items are set based on the above. Similarly, even if information is read by the reading process before the upper limit time elapses after the setting process in step S541 is executed, the terminal control unit 161 Set the contents of the setting items. Note that even when the information for setting the setting item that has already been set by the setting process is read in the reading process, the terminal control unit 161 resets the content of the setting item and then performs the process. is returned to step S53 to reset the standby time and start counting the standby time from 0 again. Thereby, even if the setting item is set by mistake, it is possible to easily change the setting content.

Further, the standby state continues even after the setting items are set based on the information read by the reading process. Therefore, since the terminal control unit 161 can continuously set a plurality of the setting items in the setting process, even if the operator sets the contents of a plurality of the setting items, There is no need to operate the wearable terminal 16 .

More specifically, the terminal control unit 161 determines the type of the setting item based on the information read from the code information, and sets the content of the setting item. For example, the terminal control unit 161 sets the display mode to the left-eye mode when information indicating that the setting item is the display mode and the content is the left-eye mode is read from the code information. set. Here, FIG. 30B is a display example when the display mode is set to the left eye mode. As shown in FIG. 30B, the terminal control unit 161 sets the display mode to the left-eye mode, and displays a message indicating that the display mode has been set to the left-eye mode on the preview screen of the setting screen D3. Pop-up display on P2. The message is automatically deleted from the setting screen D3 after a preset time has passed.

Further, the terminal control unit 161 sets the connection destination to the second device when information indicating that the setting item is the connection destination and the content is the second device number is read from the code information. do. Specifically, the terminal control unit 161 establishes a communication connection between the wearable terminal 16 and the co-infusion control unit 11 corresponding to the co-infusion support system 1 corresponding to the second machine. Further, when the co-infusion control unit 11 common to a plurality of the co-infusion support systems 1 is used, the safety cabinet 100 in which the wearable terminal 16 is used is set by the machine number etc., and the safety cabinet 100 Other correspondingly arranged components are associated with the wearable terminal 16 . Here, FIG. 30C is a display example when the connection destination is set to the second machine. As shown in FIG. 30C, the terminal control unit 161 sets the connection destination to the second machine, and displays a message indicating that the connection destination has been set to the second machine on the preview screen P2 of the setting screen D3. Show popup. The message is automatically deleted from the setting screen D3 after a preset time has passed.

Further, one piece of code information includes information about a plurality of setting items, and the terminal control unit 161 can read the contents of the plurality of setting items at once based on the information read from the piece of code information. It is conceivable to set Specifically, when a total of four pieces of code information are prepared for the two types of setting items, the display mode and the connection destination, the display mode is determined based on information read from one piece of code information. and the machine number, a total of four combinations can be set. For example, it is possible that the display mode is set to the left-eye mode and the connection destination is set to the second machine based on the information read from one piece of code information.

Further, if the same operator is used, it is conceivable that the contents of each of the setting items set on the wearable terminal 16 are always the same. Therefore, it is conceivable that the terminal control unit 161 sets the contents of each of the setting items for each worker who uses the wearable terminal 16 . Specifically, the contents of each of the setting items corresponding to each worker are stored in advance in the storage unit 173, and the terminal control unit 161 can identify the worker from the code information is read, the content of each of the setting items corresponding to the worker may be read from the storage unit 173 and set. For example, after a worker logs in to the wearable terminal 16 or the co-infusion control unit 11, the terminal control unit 161 associates the contents of each of the latest setting items set in the setting process with the worker. It is conceivable that the data is stored in the storage unit 173 as described above. The contents of the setting items corresponding to each worker are stored in the storage unit 113 of the co-infusion control unit 11, and the terminal control unit 161 selects the settings corresponding to each worker from the storage unit 113. The content of the item may be read. Further, when the co-infusion support system 1 includes a plurality of the wearable terminals 16, the storage unit 173 of one of the wearable terminals 16 stores the contents of the setting items corresponding to each worker. The terminal control unit 161 may read the contents of the setting items corresponding to each worker from the storage unit 173 of the other wearable terminal 16 .

<Step S56>
When it is determined that the waiting time is equal to or longer than the upper limit time, the terminal control section 161 cancels the waiting state in which the reading process can be executed in step S56. That is, after the wearable terminal 16 is activated and transitioned to the standby state, if information is not read by the reading process until the upper limit time elapses, the terminal control unit 161 returns to the standby state. release. Similarly, the terminal control unit 161 may also perform the above-mentioned processing when information is not read by the above-mentioned reading processing before the upper limit time elapses after the processing for setting the setting items in step S541 is executed. Release the standby state. Therefore, in the setting process, the terminal control unit 161 can automatically terminate the setting process on condition that information is not read from the code information within the upper limit time. , there is no need to manually operate the wearable terminal 16 even when the contents of the setting items are not set.

<Step S57>
In step S57, the terminal control unit 161 determines that one or a plurality of setting items that can be set for the wearable terminal 16 include unset items that have not been set based on the information read by the reading process in the standby state. If it exists, the unset item is set based on the history stored in the storage unit 173 . Specifically, the terminal control unit 161 sets the content of the unset item to the latest history state stored in the storage unit 173 . Note that the terminal control unit 161 accumulates a history of the setting items that were set in the wearable terminal 16 in the past in the storage unit 173 and stores the history in the storage unit 173, or stores the latest setting items in the storage unit 173. It is conceivable to store only the history in the storage unit 173 .

<Step S58>
In step S58, the terminal control section 161 starts the display control process (see FIG. 7). As a result, in the wearable terminal 16, the content of each work process of the co-infusion work is sequentially displayed on the terminal display unit 162, and the co-infusion work by the operator is supported. At this time, in the display control process, the terminal control section 161 causes the terminal display section 162 to display the content of each work process according to the setting content of each of the setting items set in the setting process.

As described above, in the co-infusion support system 1, the wearable terminal 16 transitions to the standby state when activated, and the contents of the setting items are set based on the information read in the reading process. , it is possible for the operator to set one or more of the setting items without manual operation.

Further, when information is read from the code information in step S54, the terminal control unit 161 determines the type of setting item corresponding to the information and sets the content of the setting item. A configuration has been described in which the plurality of setting items can be set in any order. On the other hand, the terminal control unit 161 displays a screen prompting reading of the code information for the plurality of preset setting items in a preset order, and shows the contents of the setting items corresponding to the display. It is also conceivable as another embodiment to sequentially set the contents of each of the setting items by sequentially reading the information from the code information.

The type of the setting item is not limited to the display mode and the connection destination, and may be various setting items related to the operation of the wearable terminal 16 or the co-infusion control unit 11 . For example, when the co-infusion support system 1 includes a plurality of imaging units, an imaging unit used in an imaging process such as the solution imaging step or the drug solution imaging step included in the co-infusion work is selected from the plurality of imaging units. An example of the setting item is the setting for For example, the mixed injection support system 1 is fixed together with the operation display unit 12 and the first reading unit 13 in addition to the imaging unit 163 of the wearable terminal 16, or is fixed to the safety cabinet 100. It is conceivable to provide a fixed imaging unit used in In this case, in the setting process, the terminal control unit 161 selects either the image capturing unit 163 or the fixed image capturing unit as the image capturing unit to be used in the image capturing process based on the information read from the code information. can be considered.

Further, in the co-infusion support system 1, it is conceivable that the display contents of each work process included in the co-infusion work can be changed according to the skill level of the operator or the operator's preference. Specifically, the terminal control unit 161 has a simple mode for simply displaying the contents of the work process and a detailed mode for displaying the details of the work process. It is conceivable to switch between the simple mode and the detailed mode according to the information read in the reading process in the process. In this case, a setting for switching between the simple mode and the detailed mode can be considered as an example of the setting item. For example, in the extraction process such as the dissolution liquid extraction process or the drug solution extraction process, when it is necessary to extract the solution or the drug solution in multiple extraction processes using the syringe specified in the preparation data, the detailed mode In , the extraction amount corresponding to each of the extraction steps is sequentially displayed on the terminal display screen D2, and in the simple mode, the total extraction amount is displayed on the terminal display screen D2. Further, when a weighing process such as the solution weighing process or the drug weighing process is executed, in the detailed mode, a sampling display screen prompting the user to pull out the solution or drug to be weighed in the weighing process using a syringe is displayed. It is conceivable that the weighing screen is displayed after being displayed, and the weighing screen is displayed without displaying the sampling display screen in the simple mode.

Further, in the co-infusion support system 1, the co-infusion control unit 11 may switch between enabling and disabling the drug image display function according to the information read in the reading process in the setting process. That is, it is conceivable that the setting for switching between enabling and disabling the medicine image display function is an example of the setting item.

1 co-infusion support system 11 co-infusion control unit 12 operation display unit 13 first reading unit 14 printer 15 foot switch unit 16 wearable terminal 161 terminal control unit 162 terminal display unit 163 imaging unit 164 terminal operation unit 165 speaker 166 microphone 21 second reading unit 22 weighing unit

Claims (3)

A co-infusion support system comprising a control unit for displaying information on a work process included in a drug co-infusion work on a display unit,
The control unit
switchable between a first display mode and a second display mode;
When the information of the work process to be displayed on the display unit is the information of the extraction process in which the dissolution solution or the drug solution is extracted in a plurality of times with a syringe, in the first display mode, the extraction amount of each time in the extraction process is sequentially displayed. display, and in the second display mode, display the total amount of extraction in the extraction step;
Mixed injection support system. The control unit
In the first display mode, displaying a display screen prompting to extract the solution or the drug solution with a syringe before displaying information on the weighing process of weighing the solution or the drug solution,
In the second display mode, the display screen prompting to extract the solution or the drug solution with a syringe is not displayed before displaying the information of the weighing process for weighing the solution or the drug solution.
The co-infusion support system according to claim 1. a display step of displaying information on a work process included in a drug co-injection work on a display unit;
switching between a first display mode and a second display mode;
A program for causing a processor to execute
In the display step, when the information of the working process to be displayed on the display unit is the information of the extracting process in which the dissolution solution or the drug solution is extracted in a plurality of times with a syringe, each time in the extracting process in the first display mode. sequentially display the amount of extraction, and in the second display mode, display the total amount of extraction in the extraction step;
program.

Images